image
Healthcare - Biotechnology - NASDAQ - US
$ 7.61
4.1 %
$ 1.21 B
Market Cap
-6.24
P/E
Price Target Average
113.53%
Revenue Forecast Estimate
84.29%
EBIT Estimate
--43.82%
Net Income Estimate
33.28%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Ocular Therapeutix, Inc.
image
Wall Street analysts predict an average 1-year price target for OCUL of $16.2 , with forecasts ranging from a low of $14 to a high of $19 .
OCUL Lowest Price Target Wall Street Target
14 USD 83.97%
OCUL Average Price Target Wall Street Target
16.2 USD 113.53%
OCUL Highest Price Target Wall Street Target
19 USD 149.67%
Price
Max Price Target
Min Price Target
Average Price Target
202018181616141412121010886644Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart OCUL

image
$800.0m$800.0m$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart OCUL

image
$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)($600.0m)($600.0m)($700.0m)($700.0m)($800.0m)($800.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart OCUL

image
$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029